October 2024's Top ASX Penny Stocks

Over the last 7 days, the Australian market has dropped 1.5%, but it is up 19% over the past year, with earnings forecast to grow by 12% annually. In light of these conditions, identifying stocks with strong financials can be key to navigating potential opportunities and risks. Penny stocks, though a somewhat outdated term, still represent smaller or newer companies that may offer affordability and growth potential; this article will explore three such stocks on the ASX that stand out for their financial strength.

Top 10 Penny Stocks In Australia

Name	Share Price	Market Cap	Financial Health Rating
LaserBond (ASX:LBL)	A$0.61	A$66.82M	★★★★★★
Embark Early Education (ASX:EVO)	A$0.80	A$126.84M	★★★★☆☆
MaxiPARTS (ASX:MXI)	A$1.87	A$100.95M	★★★★★★
Austin Engineering (ASX:ANG)	A$0.55	A$310.07M	★★★★★☆
Helloworld Travel (ASX:HLO)	A$1.845	A$298M	★★★★★★
Navigator Global Investments (ASX:NGI)	A$1.72	A$833.14M	★★★★★☆
Perenti (ASX:PRN)	A$1.19	A$1.1B	★★★★★★
Atlas Pearls (ASX:ATP)	A$0.135	A$58.82M	★★★★★★
GTN (ASX:GTN)	A$0.47	A$92.11M	★★★★★★
Joyce (ASX:JYC)	A$3.915	A$115.04M	★★★★★★

Click here to see the full list of 1,031 stocks from our ASX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Djerriwarrh Investments (ASX:DJW)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Djerriwarrh Investments Limited is a publicly owned investment manager with a market capitalization of A$857.08 million.

Operations: The company generates revenue primarily through its portfolio of investments, amounting to A$53.38 million.

Market Cap: A$857.08M

Djerriwarrh Investments Limited, with a market capitalization of A$857.08 million, generates revenue primarily through its investment portfolio, reporting A$53.38 million for the year ended June 30, 2024. Despite negative earnings growth over the past year and a low return on equity at 4.5%, the company maintains high-quality earnings and stable weekly volatility (2%). Its short-term assets exceed both short-term and long-term liabilities significantly, while debt levels are well-covered by operating cash flow (402.1%). Recent board changes include Catherine Brenner's appointment as Non-Executive Director following Alice Williams' retirement after her long tenure since May 2010.

• Click to explore a detailed breakdown of our findings in Djerriwarrh Investments' financial health report.
• Evaluate Djerriwarrh Investments' historical performance by accessing our past performance report.

Environmental Group (ASX:EGL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: The Environmental Group Limited specializes in the design, application, and servicing of gas, vapor, and dust emission control systems as well as inlet and exhaust systems for gas turbines, with a market cap of A$152.20 million.

Operations: The company's revenue is primarily derived from its segments: EGL Waste (A$0.85 million), EGL Energy (A$37.86 million), Egl Clean Air Tapc (A$17.40 million), Egl Clean Air Airtight (A$15.54 million), and EGL Turbine Enhancement (A$27.13 million).

Market Cap: A$152.2M

The Environmental Group Limited, with a market cap of A$152.20 million, has shown robust earnings growth of 68% over the past year, outpacing the industry average. The company's revenue stands at A$98.25 million for the year ending June 30, 2024, with net income rising to A$4.39 million from A$2.61 million previously. Its debt is well-managed and covered by operating cash flow (2807.6%), while short-term assets exceed liabilities significantly. Recent board changes include Lucia Cade's appointment as an Independent Non-Executive Director and Graeme Nayler's retirement, signaling a strategic focus on sustainable growth and governance enhancement.

• Navigate through the intricacies of Environmental Group with our comprehensive balance sheet health report here.
• Gain insights into Environmental Group's future direction by reviewing our growth report.

XRF Scientific (ASX:XRF)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries across Australia, Canada, and Europe with a market cap of A$226.04 million.

Operations: The company's revenue is derived from three primary segments: Consumables generating A$18.82 million, Precious Metals contributing A$21.50 million, and Capital Equipment accounting for A$21.75 million.

Market Cap: A$226.04M

XRF Scientific Limited, with a market cap of A$226.04 million, reported sales of A$60.12 million for the year ending June 30, 2024, marking an increase from the previous year. The company's net income rose to A$8.89 million, reflecting strong earnings growth of 15.6%, which surpasses industry trends and highlights its high-quality earnings profile. XRF's financial health is robust with short-term assets covering both short and long-term liabilities comfortably and more cash than total debt. Its experienced management team and board further strengthen its operational stability while trading below estimated fair value suggests potential investment appeal in the penny stock segment.

• Click here to discover the nuances of XRF Scientific with our detailed analytical financial health report.
• Examine XRF Scientific's earnings growth report to understand how analysts expect it to perform.

Turning Ideas Into Actions

• Jump into our full catalog of 1,031 ASX Penny Stocks here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com